Patients receiving nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids (<= 10 mg per day), or both are eligible if the dosage has been stable for at least four weeks before treatment and remained so throughout the study and follow-up period (the use of narcotics for pain flares is allowed). [clinicaltrials_resource:29d3363f9dda597455df7f1d8d8e92e8]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Patients receiving nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids (<= 10 mg per day), or both are eligible if the dosage has been stable for at least four weeks before treatment and remained so throughout the study and follow-up period (the use of narcotics for pain flares is allowed). [clinicaltrials_resource:29d3363f9dda597455df7f1d8d8e92e8]
Bio2RDF identifier
29d3363f9dda597455df7f1d8d8e92e8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:29d3363f9dda597455df7f1d8d8e92e8
identifier
clinicaltrials_resource:29d3363f9dda597455df7f1d8d8e92e8
title
Patients receiving nonsteroida ...... s for pain flares is allowed).
@en
type
label
Patients receiving nonsteroida ...... 3363f9dda597455df7f1d8d8e92e8]
@en